In the first head-to-head trial comparing two popular weight loss drugs, Mounjaro (tirzepatide) was found to be more effective than competitor Wegovy (semaglutide).
Global health insurer Bupa aims to build a network of 130 medical centres over the next three years in Australia, with plans to invest in GP clinics and partner with hospitals to provide services.
This week’s infographic uses HBI’s provider database to look at the top 5 elderly care providers in the UK with US investors in 2023. US capital in the UK elderly care market skyrocketed in 2024 and shows an upward trend as a growing dominant force in the UK market contributing to 68% of the total […]
FutureLife, a pan-European provider of IVF and genetics services co-owned by Luxembourg-based private equity firm CVC Capital Partners and Central Europe-based private equity firm Hartenberg Holding, has reached an agreement to acquire a stake in the Bahceci Group.
The UK and India have concluded a Free Trade Agreement (FTA) as of 6 May, following three years of discussions. Though not yet formally signed, the agreement is expected to deepen economic ties, with UK government projections estimating a £25.5 billion boost to annual trade, a £4.8 billion increase in GDP, and a £2.2 billion rise in wages over the long term.
The UK government’s new visa policy announcement, scrapping visas for care workers, has sent ripples of concern through England’s care sector. For operators and investors in elderly care and supported living facilities already navigating challenging conditions, such as those introduced by the recent increase in employer National Insurance contributions, this shift represents a significant operational […]
The government has announced plans to reduce immigration in the UK and focus the system towards “those who contribute most to economic growth” with “higher skills standards” as well as training within the UK. As part of a white paper, the plan to lower “record-high levels of net migration” and end the “reliance on international recruitment” will include the end of overseas recruitment for social care visas, in a further hurdle to overcome for the sector.
It has been claimed GLP-1 drugs like Ozempic and Mounjaro could be available to NHS patients over the counter at pharmacies, according to news reports.
Vespa Capital, a UK private equity firm focused on lower mid-market investments, has invested in FibroFind, a contract research organisation that has a patented technology which enables testing to be carried out on human tissue rather than animals.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
